https://www.selleckchem.com/products/1-nm-pp1.html
Vitamin A (VA) stores are low in early infancy and may impair development of the immune system. This study determined if neonatal VA supplementation (VAS) affects the following 1) development of regulatory T (Treg) cells; 2) chemokine receptor 9 (CCR9) expression, which directs mucosal targeting of immune cells; and 3) systemic endotoxin exposure as indicated by changed plasma concentrations of soluble CD14 (sCD14). Secondarily, VA status, growth, and systemic inflammation were investigated. In total, 306 Bangladeshi infants were rando